Losartan Potassium Tablets Recalled for Blue Plastic Contamination
Strides Pharma Inc. is recalling Losartan Potassium Tablets, 25 mg, due to the presence of blue plastic pieces embedded in tablets from lot 7901903A. No illnesses or injuries have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving foreign material (plastic) in a tablet, presenting a potential choking hazard. No illnesses, injuries, or hospitalizations have been reported. Per the rubric, risk-of-harm products without reported injury score at most 3.
Plain-English summary
Strides Pharma Inc. is recalling Losartan Potassium Tablets, USP, 25 mg, due to the presence of a small piece of blue plastic embedded in tablets. The affected product is from lot 7901903A with an expiration date of April 2024. This recall was issued under FDA Class II classification.
Approximately 2,700 bottles of the affected product were distributed nationwide throughout the United States. Losartan Potassium is a prescription medication used to treat high blood pressure.
No illnesses or injuries have been reported in connection with this recall. Consumers who have received this product from the affected lot should stop using it and contact their pharmacy or healthcare provider for a replacement.
The recalled product
- Product
- LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)
- Brand
- LOSARTAN POTASSIUM
- Manufacturer
- Strides Pharma Inc.
- Category
- Drug
- Hazard
- foreign-substance
- choking
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 7901903A
- exp. date 04/2024
UPCs (9)
- 0364380933052
- 0364380935056
- 0364380935087
- 0364380935049
- 0364380934042
- 0364380933045
- 0364380934080
- 0364380933083
- 0364380934059
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LOSARTAN POTASSIUM
- HighLosartan Potassium tablets recalled for elevated AZIDO impurity
FDA (Drugs) · 2022-07-06
- HighLosartan Potassium Tablets Recalled for Elevated AZIDO Impurity Levels
FDA (Drugs) · 2022-07-06
- HighLosartan Potassium Tablets Recalled for Manufacturing Impurity Issues
FDA (Drugs) · 2022-07-06
- ModerateLosartan Potassium tablets recalled for excessive AZIDO impurity
FDA (Drugs) · 2022-06-08
- HighLosartan Potassium Tablets Recalled for Elevated AZIDO Impurity Levels
FDA (Drugs) · 2022-06-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27